Antimicrobial Resistance Pattern of Bacterial Isolates from ICU Patients in a Tertiary Care Hospital
DOI:
https://doi.org/10.66984/jsmdc.v12.i01.oa.06Keywords:
Drug resistance, Bacterial infections, Anti-bacterial agents, Intensive care unitsAbstract
Objective: To determine the frequency and antimicrobial resistance (AMR) pattern of bacterial isolates among intensive care unit (ICU) patients in a tertiary care hospital.
Methodology: This cross-sectional descriptive study was carried out in the Microbiology Laboratory of Provincial Headquarter Hospital, Gilgit, from October 2025 to March 2026 after ethical approval. After taking informed consent, 150 culture specimens received from ICU patients were tested by non-probability consecutive sampling. Each specimen was inoculated onto the appropriate culture media, then incubated and carefully identified based on colony morphology, Gram stain, and biochemical tests. The antimicrobial sensitivity testing (AST) was performed by the Kirby-Bauer disc diffusion method. The antibiotic zone diameters were reported following the Clinical and Laboratory Standards Institute (CLSI) guidelines 2025. The statistical analysis was done by the Statistical Package for the Social Sciences (SPSS) version 27.
Results: The most common pathogen isolated was Staphylococcus (31.6%), succeeded by Escherichia coli (17.3%), Klebsiella pneumoniae (15.3%), Pseudomonas aeruginosa (13.3%), Acinetobacter baumannii (10.2%), Enterococcus species (9.2%), and Proteus species (3.1%). Staphylococcus aureus, Coagulase-negative Staphylococcus species (CoNS) and Enterococcus species were sensitive to vancomycin and linezolid. Staphylococcus aureus and CoNS showed less resistance to gentamicin (35.7% versus 23.5%) and doxycycline (28.6% and 17.6%). Carbapenems showed 100% susceptibility in all Gram-negative isolates. Piperacillin-tazobactam, amikacin and nitrofurantoin showed better sensitivities as compared to other antibiotics. Escherichia coli, Klebsiella pneumoniae, Proteus and Pseudomonas showed 29.4%, 33.3%, 0% & 38.5% resistance to piperacillin-tazobactam and 17.6%, 20%, 33.3% & 46.1% to amikacin. Resistance to nitrofurantoin was 27.3% for E. coli, 0% for Klebsiella pneumoniae, and Proteus species. Acinetobacter baumannii exhibited higher antibiotic resistance.
Conclusion: Gram-negative bacteria constituted 59.2%, whereas Gram-positive bacteria made up 40.8% of the isolates. Around 71.4% isolates of Staphylococcus aureus were methicillin-resistant and 70.6% Escherichia coli & 73.3% Klebsiella pneumoniae were extended-spectrum beta-lactamase (ESBL) producers. A higher antimicrobial resistance was seen in the isolates.
References
1. Calvo M, Stefani S, Migliorisi G. Bacterial infections in intensive care units: epidemiological and microbiological aspects. Antibiotics (Basel). 2024; 13(3):238. doi:10.3390/ antibiotics13030238.
2. Duhaniuc A, Paduraru D, Nastase EV, Trofin F, Iancu LS, Sima CM, et al. Multidrug-resistant bacteria in immunocompromised patients. Pharmaceuticals (Basel). 2024; 17(9):1151. doi:10.3390/ph17091151.
3. Osman AH, Darkwah S, Kotey FCN, Odoom A, Hotor P, Dayie NTKD, et al. Reservoirs of nosocomial pathogens in intensive care units: a systematic review. Environ Health Insights. 2024; 18:11786302241243239. doi:10.1177/ 11786302241243239.
4. Odoom A, Donkor ES. Prevalence of healthcare-acquired infections among adults in intensive care units: a systematic review and meta-analysis. Health Sci Rep. 2025; 8(7):e70939. doi:10.1002/hsr2.70939.
5. Saharman YR, Karuniawati A, Severin JA, Verbrugh HA. Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review. Antimicrob Resist Infect Control. 2021; 10(1):22. doi:10.1186/s13756-020-00871-x.
6. Princess I, Vadala R. Clinical microbiology in the intensive care unit: time for intensivists to rejuvenate this lost art. Indian J Crit Care Med. 2021; 25(5):566-74. doi:10.5005/ jp-journals-10071- 23810.
7. Al Hajjeh RJ, Maniamma PM, Rego JL, Awwad M, Nsutebu EF. Right approach: improvement in cleaning and disinfection of medical equipment in use - Sheikh Shakhbout Medical City (SSMC) experience. BMJ Open Qual. 2025; 14(2):e002958. doi:10.1136/bmjoq-2024-002958.
8. Khan JZ, Ismail M, Ullah R, Ali W, Ali I. Increased burden of MDR bacterial infections; reflection from an antibiogram of ICUs of a tertiary care hospital. J Infect Dev Ctries. 2023; 17(7):994-8. doi:10.3855/jidc.18142.
9. Lewis II JS. CLSI M100-Ed35 Performance Standards for Antimicrobial Susceptibility Testing Standards. 35th Ed. 2025. Clinical and Laboratory Standards Institute.
10. Piscitelli P, Costigliola V, Azamfirei L. The challenge of antimicrobial resistance in intensive care setting. J Crit Care Med (Targu Mures). 2025; 11(2):109-11. doi:10.2478/ jccm-2025-0020.
11. Montrucchio G, Sales G, Catozzi G, Bosso S, Scanu M, Vignola TV, et al. Effectiveness of an active and continuous surveillance program for intensive care units infections based on the EPIC III (Extended Prevalence of Infection in Intensive Care) approach. J Clin Med. 2022; 11(9):2482. doi:10.3390/jcm11092482.
12. Chakraborty M, Sardar S, De R, Biswas M, Mascellino MT, Miele MC, et al. Current trends in antimicrobial resistance patterns in bacterial pathogens among adult and pediatric patients in the intensive care unit in a tertiary care hospital in Kolkata, India. Antibiotics (Basel). 2023; 12(3):459. doi:10.3390/antibiotics12030459.
13. Altaf A, Yahya S, Saleem T. Prevalence and antibiotic susceptibility pattern of bacterial pathogens in intensive care unit (ICU) of a tertiary care facility. BioSight. 2023; 4(2-3):14-22. doi:10.46568/bios.v4i2-3.124.
14. Suresh, Hussain SA, Vinod R, Pradeepa A. Clinical profile of intensive care unit (ICU) patients with infections and antibiotic response in a tertiary care hospital. Int J Environ Sci. 2025; 11(23s):3275-89. doi:10.64252/nd9 wqt56.
15. Kumar A, Chaudhry D, Goel N, Tanwar S. Epidemiology of intensive care unit-acquired infections in a tertiary care hospital of North India. Indian J Crit Care Med. 2021; 25(12):1427-33. doi:10.5005/jp-journals-10071-24058.
16. Saleem M, Syed Khaja AS, Hossain A, Alenazi F, Said KB, Moursi SA, et al. Pathogen burden among ICU patients in a tertiary care hospital in Hail Saudi Arabia with particular reference to β- lactamases profile. Infect Drug Resist. 2023; 16:769-78. doi:10.2147/IDR.S394777.
17. Wang X, Liu Y, Ding Y, Li M, Gao Y, Li T. Disease spectrum of patients with hospital-acquired multidrug-resistant organism infections in the intensive care unit: a retrospective study. Front Microbiol. 2025; 16:1568615. doi:10.3389/fmicb.2025.1568615.
18. Umadevi S. A study on microbiological profile of MDR pathogens in ICU in a tertiary care hospital. EJCM. 2023; 13(4):1412-7. doi:10.5083/ejcm/2023.
19. Kumar M, Burri RR, Jauhari S. Emergence of multidrug-resistant pathogens in a tertiary care hospital in Northern India: a comparative study between critical care units and wards. Cureus. 2026; 18(4):e107448. doi:10.7759/cureus. 107448.
20. Bhagat S, Singh T, Priya S, Sharma SS. Prevalence and antimicrobial resistance profile of ESBL- producing Enterobacteriaceae isolated from intensive care unit patients in a tertiary care hospital. J Popul Ther ClinPharmacol. 2025; 32(10):538-49. doi:10.53555/ 7xdgwk27.
21. Khursheed N, Adnan F, Khan MA, Hatif R. Regional insights on the prevalence and antimicrobial susceptibility pattern of carbapenem and colistin-resistant Gram-negative bacteria: an observational cross-sectional study from Karachi, Pakistan. BMC Infect Dis. 2025 Feb 7; 25(1):186. doi: 10.1186/s12879-025-10535-z.
22. Fatima M, Dodani SK, Babar ZU, Badlani S, Rani B, Mushtaq M, et al. Outcome, risk factors and therapeutic strategies in carbapenem-resistant Gram-negative bacteraemia from Pakistan. JAC Antimicrob Resist. 2023 Jun 14; 5(3):dlad076. doi: 10.1093/jacamr/dlad076.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Journal of Sharif Medical & Dental College is licensed and distributed under the terms of Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
